Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 8651–8700 of 33509
On July 5, 2024, Edgardo Baracchini informed INmune Bio Inc. (the “Company”) of his resignation from the board of directors of the Company (the “Board”), effective immediately.
each of the Company’s directors immediately prior to the Effective Time (Stanley P. Jaworski, Steve Smith, William Cooke, Richard Bravman, Michael N. Taglich and John Guttilla) resigned as directors of the Company.
each of the Company’s directors immediately prior to the Effective Time (Stanley P. Jaworski, Steve Smith, William Cooke, Richard Bravman, Michael N. Taglich and John Guttilla) resigned as directors of the Company.
each of the Company’s directors immediately prior to the Effective Time (Stanley P. Jaworski, Steve Smith, William Cooke, Richard Bravman, Michael N. Taglich and John Guttilla) resigned as directors of the Company.
each of the Company’s directors immediately prior to the Effective Time (Stanley P. Jaworski, Steve Smith, William Cooke, Richard Bravman, Michael N. Taglich and John Guttilla) resigned as directors of the Company.
each of the Company’s directors immediately prior to the Effective Time (Stanley P. Jaworski, Steve Smith, William Cooke, Richard Bravman, Michael N. Taglich and John Guttilla) resigned as directors of the Company.
each of the Company’s directors immediately prior to the Effective Time (Stanley P. Jaworski, Steve Smith, William Cooke, Richard Bravman, Michael N. Taglich and John Guttilla) resigned as directors of the Company.
Effective August 16, 2024, Chief Operating Officer Brian Wuebbels has resigned from Complete Solaria, Inc. (the “Company”).
On July 2, 2024, Christa Davies submitted her resignation from the Board of Directors (the “Board”) of Workday, Inc. (“Workday”), including from the Audit Committee of the Board (the “Audit Committee”), effective immediately.
On June 28, 2024, Teladoc Health, Inc. (the “Company”) terminated without cause the employment of Laizer Kornwasser, President, Enterprise Growth and Global Markets, in connection with a change in the Company's executive reporting structure, effective July 1, 2024.
On July 1, 2024, the Board of Directors of the Company terminated Timothy Woods as the Company’s Chief Financial Officer and appointed Todd Peterson as the Company’s new Chief Financial Officer.
On July 2, 2024, Joerg Sommer resigned as the Company’s President, effective immediately.
On July 1, 2024, Bandwidth Inc., a Delaware corporation (the “Company”), entered into a letter agreement (the “Bartolo Letter Agreement”) with Anthony F. Bartolo, the Company’s outgoing Chief Operating Officer, in connection with his resignation.
On July 1, 2024, Prudence Kuai informed the Board of Directors (the “Board”) of HF Foods Group Inc. (the “Company”) of her intention to resign from the Board and all committees thereof, effective July 5, 2024.
Effective July 5, 2024, Sally Kin Yi Lo resigned from her positions as the Chief Executive Officer, Chief Financial Officer, Secretary and Director of DH Enchantment, Inc. (the "Company").
On June 28, 2024, the Board of Directors (the “Board”) of Unicoin Inc. (the “Company”) resolved that Pilar Manch ó n’s initial term as a director on the Board had expired and acknowledged that as of June 28, 2024, Ms. Manch ó n shall no longer serve on the Board.
Mr. Ken Sanders, who announced his intention to retire from the Board of Directors on June 30, 2024
On July 2, 2024, Inogen, Inc. (the “Company”) and Jason Somer, Executive Vice President, General Counsel and Secretary of the Company, mutually determined that Mr. Somer would separate from the Company on July 19, 2024.
At the same Board meeting, MAS formally informed the Board of his intention that his long anticipated retirement from his various positions (including Director, President, Interim Chief Financial Officer and General Counsel) at the Company (and its subsidiaries) begin effective the end of business on July 31, 2024.
the Company and Joshua Parnes, the Company’s President, mutually agreed that Mr. Parnes will resign from all positions that he holds with the Company and its affiliates, effective as of 11:59 p.m. E.D.T. on August 31, 2024
On July 2, 2024, biote Corp. (the “Company”) announced that Mary Puncochar, who has served as the Company’s Head of Strategic Sales & Business Analytics since March 2024 and, prior to that, served as Chief Commercial Officer from May 2023 to March 2024, was terminated other than for cause from all employment and officer positions with the Company.
Effective as of June 30, 2024 (the “Separation Date”), Danish Qureshi’s employment as President and Chief Operating Officer of LifeStance Health Group, Inc. (“LifeStance” or the “Company”) terminated.
On June 28, 2024, Ashley M. Keating, a member of the Board of Directors (the “Board”) of Medpace Holdings, Inc. (the “Company”) notified the Company of her resignation, effective as of June 30, 2024.
As previously disclosed by Ashford Hospitality Trust, Inc. (the “ Company ”), on April 17, 2024, J. Robison Hays, III, President and Chief Executive Officer of the Company, gave notice of his intention to voluntarily resign from his employment and all other employment-related positions he holds with the Company’s advisor, Ashford Inc., and its subsidiaries, affiliated entities, and entities that it advises (including the Company).
On July 1, 2024, J. Bradley Campbell resigned from service on the Company’s Board of Directors (the “Board”) and all subcommittees of the Board effective immediately.
On July 1, 2024, Cynthia Williams notified the Board of Directors (the “Board”) of Aterian Inc. (the “Company”) of her intent to not stand for reelection at the Company’s 2024 Annual Meeting of Stockholders (the “Annual Meeting”) and to retire from the Board effective as of the the conclusion of the Annual Meeting.
Additionally, on June 18, 2024, Vito J. Mangiardi, a member of the Board, resigned, effective immediately.
On June 18, 2024, Kevin A. Pollack, a member of the Board of Directors (the “Board”) of Pressure BioSciences, Inc. (the “Company”), resigned, effective immediately.
On July 1, 2024, each of Keith Ward, PhD and Praveen Tyle, PhD informed the Board of their intent to resign as a member of the Board, effective August 1, 2024.
On July 1, 2024, each of Keith Ward, PhD and Praveen Tyle, PhD informed the Board of their intent to resign as a member of the Board, effective August 1, 2024.
As previously disclosed by Ashford Inc. (the “ Company ”), on April 17, 2024, J. Robison Hays, III, Senior Managing Director of the Company, gave notice of his intention to voluntarily resign from his employment and all other employment-related positions he holds with the Company and its subsidiaries, affiliated entities, and entities that it advises (including in his role as President and Chief Executive Officer at Ashford Hospitality Trust, Inc. (“ Ashford Trust ”)).
Concurrent with the Bankruptcy Filing, directors Leslie C.G. Campbell, Raj Batra, Ryan Kearny, Greg Kress, Christine Gorjanc, Alberto Recchi and Josh Wolfe tendered their resignations as members of the Company’s board of directors.
Concurrent with the Bankruptcy Filing, Greg Kress, the Company’s chief executive officer, Alberto Recchi, the Company’s chief financial officer, and Andy Nied, the Company’s chief operating officer, resigned as executive officers of the Company.
Concurrent with the Bankruptcy Filing, directors Leslie C.G. Campbell, Raj Batra, Ryan Kearny, Greg Kress, Christine Gorjanc, Alberto Recchi and Josh Wolfe tendered their resignations as members of the Company’s board of directors.
Concurrent with the Bankruptcy Filing, directors Leslie C.G. Campbell, Raj Batra, Ryan Kearny, Greg Kress, Christine Gorjanc, Alberto Recchi and Josh Wolfe tendered their resignations as members of the Company’s board of directors.
Concurrent with the Bankruptcy Filing, directors Leslie C.G. Campbell, Raj Batra, Ryan Kearny, Greg Kress, Christine Gorjanc, Alberto Recchi and Josh Wolfe tendered their resignations as members of the Company’s board of directors.
Concurrent with the Bankruptcy Filing, directors Leslie C.G. Campbell, Raj Batra, Ryan Kearny, Greg Kress, Christine Gorjanc, Alberto Recchi and Josh Wolfe tendered their resignations as members of the Company’s board of directors.
Concurrent with the Bankruptcy Filing, Greg Kress, the Company’s chief executive officer, Alberto Recchi, the Company’s chief financial officer, and Andy Nied, the Company’s chief operating officer, resigned as executive officers of the Company.
Concurrent with the Bankruptcy Filing, Greg Kress, the Company’s chief executive officer, Alberto Recchi, the Company’s chief financial officer, and Andy Nied, the Company’s chief operating officer, resigned as executive officers of the Company.
on July 1, 2024, Stephen D. Brooks retired as Executive Vice President of Land, Legal, Human Resources and Marketing of the Company.
the Nomination & Governance Committee (“Committee”) of the Registrant’s Board of Directors (“Board”) received notification from Director Ernest E. Dow that he intend to retire from the Board at the Registrant’s Annual Meeting of Shareholders convened on Thursday, June 27, 2024.
Jeffrey L. DiRubio, the Precision Optics Corporation, Inc.’s (the “ Company ”) Senior Vice President of Sales and Marketing, resigned from the Company effective as of June 30, 2024.
the Company and Frederic Vanderhaegen, the Company’s former Executive Vice President, Europe, and a named executive officer in the Company’s definitive proxy statement on Schedule 14A filed on March 29, 2024, agreed that Mr. Vanderhaegen would depart from the Company on June 30, 2024.
On June 27, 2024, Leni Boeren provided notice of her resignation as a member of the Board of Directors of Renovaro Inc. (the “ Company ”), with such resignation being effective June 27, 2024.
On June 28, 2024, Alan Russo notified Stem, Inc. (the “Company”) of his intent to resign as Chief Revenue Officer of the Company, effective July 12, 2024.
On July 1, 2024, Bill Sullivan resigned from his position as a member of the Board of Directors (the “Board”) of Privia Health Group, Inc. (the “Company”) and as a member of the Audit Committee of the Board, effective immediately.
The employment of Gregg Zegras as Executive Vice President and President, Global Ecommerce at the Company ended, effective June 30, 2024
On June 30, 2024, Adrian Haigh departed from his position as Fennec Pharmaceuticals Inc.’s (the "Company") Chief Operating Officer
In connection with the Merger, at the Effective Time, the following persons are no longer serving on the Company’s board of directors: Jan M. Winston, William J. Foote, Dennis G. Romano and Rick Strandlund.
In connection with the Merger, at the Effective Time, the following persons are no longer serving on the Company’s board of directors: Jan M. Winston, William J. Foote, Dennis G. Romano and Rick Strandlund.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.